# US 2012/0252841 A1 · Substituted 2-mercaptoquinoline-3-carboxamides as KCNQ2/3 modulators

> Agents: this data is available as JSON from the patentgrep API and MCP server — see https://patentgrep.com/llms.txt

- Number: US 2012/0252841 A1
- Document ID: US20120252841A1
- Status: Published application
- Kind: A1
- Application number: 13/523,955
- Filed: 2012-06-15
- Published: 2012-10-04
- Earliest claimed: 2009-03-12
- Assignees: Drunenthal GmbH
- Inventors: Sven KÜHNERT; Gregor BAHRENBERG; Achim KLESS; Wolfgang SCHRÖDER
- Web page: https://patentgrep.com/patent/US20120252841A1

## CPC

- C07D 409/12: linked by a chain containing hetero atoms as chain links
- A61P 13/02: of urine or of the urinary tract, e.g. urine acidifiers
- A61P 13/06: Anti-spasmodics
- A61P 21/00: Drugs for disorders of the muscular or neuromuscular system
- A61P 25/00: Drugs for disorders of the nervous system
- A61P 25/04: Centrally acting analgesics, e.g. opioids
- A61P 25/06: Antimigraine agents
- A61P 25/08: Antiepileptics; Anticonvulsants
- A61P 25/14: for treating abnormal movements, e.g. chorea, dyskinesia
- A61P 25/18: Antipsychotics, i.e. neuroleptics; Drugs for mania or schizophrenia
- A61P 25/22: Anxiolytics
- A61P 25/28: for treating neurodegenerative disorders of the central nervous system, e.g. nootropic agents, cognition enhancers, drugs for treating Alzheimer's disease or other forms of dementia
- A61P 25/30: for treating abuse or dependence
- A61P 29/00: Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A61P 43/00: Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- C07D 215/54: attached in position 3
- C07D: HETEROCYCLIC COMPOUNDS (macromolecular compounds C08)
- A61P: SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS

## Abstract

The invention relates to substituted 2-mercaptoquinoline-3-carboxamides, methods for the preparation thereof, medicaments containing these compounds and the use of these compounds for the preparation of medicaments.

## Claims

### Claim 1

A substituted 2-mercaptoquinoline-3-carboxamide having the formula (1):
wherein
R0 stands for C1-10 alkyl or C2-10 heteroalkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted; C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted; aryl or heteroaryl, each unsubstituted or mono- or polysubstituted; C1-8 alkyl- or C2-8 heteroalkyl-bridged C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted, wherein the alkyl or heteroalkyl chain can in each case be branched or unbranched, saturated or unsaturated, unsubstituted, mono- or polysubstituted; or C1-8 alkyl- or C2-8 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted, wherein the alkyl or heteroalkyl chain can in each case be branched or unbranched, saturated or unsaturated, unsubstituted, mono- or polysubstituted;
R1, R2, R3, R4 each denote independently of one another H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)H; C(═O)R0; CO2H; C(═O)OR0; CONH2; C(═O)NHR0; C(═O)N(R0)2; OH; OR0; O—C(═O)—R0; O—C(═O)—O—R0; O—(C═O)—NH—R0; O—C(═O)—N(R0)2; O—S(═O)2—R0; O—S(═O)2OH; O—S(═O)2OR0; O—S(═O)2NH2; O—S(═O)2NHR0; O—S(═O)2N(R0)2; NH2; NH—R0; N(R0)2; NH—C(═O)—R0; NH—C(═O)—O—R0; NH—C(═O)—NH2; NH—C(═O)—NH—R0; NH—C(═O)—N(R0)2; NR0—C(═O)—R0; NR0—C(═O)—O—R0; NR0—C(═O)—NH2; NR0—C(═O)—NH—R0; NR0—C(═O)—N(R)2; NH—S(═O)2OH; NH—S(═O)2R0; NH—S(═O)2OR0; NH—S(═O)2N(R0)2; NH—S(═O)2NHR0; NH—S(═O)2N(R0)2; NR0—S(═O)2OH; NR0—S(═O)2R0; NR0—S(═O)2OR0; NR0—S(═O)2NH2; NR0—S(═O)2NHR0; NR0—S(═O)2N(R)2; SH; SR0; S(═O)R0; S(═O)2R0; S(═O)2OH; S(═O)2OR0; S(═O)2NH2; S(═O)2NHR0; or S(═O)2N(R0)2;
R5 stands for H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)H; C(═O)R0; CO2H; C(═O)OR0; CONH2; C(═O)NHR0; C(═O)N(R0)2; OR0; O—C(═O)—R0; O—C(═O)—O—R0; O—(C═O)—NH—R0; O—C(═O)—N(R0)2; O—S(═O)2—R0; O—S(═O)2OH; O—S(═O)2OR0; O—S(═O)2NH2; O—S(═O)2NHR0; O—S(═O)2N(R0)2; NH2; NH—R0; N(R0)2; NH—C(═O)—R0; NH—C(═O)—O—R0; NH—C(═O)—NH2; NH—C(═O)—NH—R0; NH—C(═O)—N(R0)2; NR0—C(═O)—R0; NR0—C(═O)—O—R0; NR0—C(═O)—NH2; NR0—C(═O)—NH—R0; NR0—C(═O)—N(R0)2; NH—S(═O)2OH; NH—S(═O)2R0; NH—S(═O)2OR0; NH—S(═O)2NH2; NH—S(═O)2NHR0; NH—S(═O)2N(R)2; NR0—S(═O)2OH; NR0—S(═O)2R0; NR0—S(═O)2OR0; NR0—S(═O)2NH2; NR0—S(═O)2NHR0; NR0—S(═O)2N(R0)2; SH; SR0; S(═O)R0; S(═O)2R0; S(═O)2OH; S(═O)2OR0; S(═O)2NH2; S(═O)2NHR0; or S(═O)2N(R)2;
R6 stands for R0, with the proviso that if R0 denotes heterocyclyl, saturated or unsaturated, unsubstituted or mono- or polysubstituted, or heteroaryl, unsubstituted or mono- or polysubstituted, then the heteroaryl or heterocyclyl is bound via a carbon atom of the heteroaryl or heterocyclyl;
R7 stands for R0, with the proviso that if R0 denotes heterocyclyl, saturated or unsaturated, unsubstituted or mono- or polysubstituted, or heteroaryl, unsubstituted or mono- or polysubstituted, then the heteroaryl or heterocyclyl is bound via a carbon atom of the heteroaryl or heterocyclyl;
wherein “substituted” in the case of substitution on alkyl, heteroalkyl, heterocyclyl and cycloalkyl stands for the substitution of one or more hydrogen atoms, each independently of one another, with F; Cl; Br; I; CN; CF3; ═O; ═NH; ═C(NH2)2; NO2; R0; C(═O)H; C(═O)R0; CO2H; C(═O)OR0; CONH2; C(═O)NHR0; C(═O)N(R0)2; OH; OR0; —O—(C1-8 alkyl)-O—; O—C(═O)—R0; O—C(═O)—O—R0; O—(C═O)—NH—R0; O—C(═O)—N(R0)2; O—S(═O)2—R0; O—S(═O)2OH; O—S(═O)2OR0; O—S(═O)2NH2; O—S(═O)2NHR0; O—S(═O)2N(R0)2; NH2; NH—R0; N(R0)2; NH—C(═O)—R0; NH—C(═O)—O—R0; NH—C(═O)—NH2; NH—C(═O)—NH—R0; NH—) C(═O)—N(R0)2; NR0—C(═O)—R0; NR0—C(═O)—O—R0; NR0—C(═O)—NH2; NR0—C(═O)—NH—R0; NR0—C(═O)—N(R0)2; NH—S(═O)2OH; NH—S(═O)2R0; NH—S(═O)2OR0; NH—S(═O)2NH2; NH—S(═O)2NHR0; NH—S(═O)2N(R)2; NR0—S(═O)2OH; NR0—S(═O)2R0; NR0—S(═O)2OR0; NR0—S(═O)2NH2; NR0—S(═O)2NHR0; NR0—S(═O)2N(R0)2; SH; SR0; S(═O)R0; S(═O)2R0; S(═O)2H; S(═O)2OH; S(═O)2OR0; S(═O)2NH2; S(═O)2NHR0; or S(═O)2N(R)2;
wherein “substituted” in the case of substitution on aryl and heteroaryl stands for the substitution of one or more hydrogen atoms, each independently of one another, with F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)H; C(═O)R0; CO2H; C(═O)OR0; CONH2; C(═O)NHR0; C(═O)N(R0)2; OH; OR0; —O—(C1-8 alkyl)-O—; O—C(═O)—R0; O—C(═O)—O—R0; O—(C═O)—NH—R0; O—C(═O)—N(R0)2; O—S(═O)2—R0; O—S(═O)2OH; O—S(═O)2OR0; O—S(═O)2NH2; O—S(═O)2NHR0; O—S(═O)2N(R)2; NH2; NH—R0; N(R0)2; NH—C(═O)—R0; NH—C(═O)—O—R0; NH—C(═O)—NH2; NH—C(═O)—NH—R0; NH—C(═O)—N(R0)2; NR0—C(═O)—R0; NR0—C(═O)—O—R0; NR0—C(═O)—NH2; NR0—C(═O)—NH—R0; NR0—C(═O)—N(R0)2; NH—S(═O)2OH; NH—S(═O)2R0; NH—S(═O)2OR0; NH—S(═O)2NH2; NH—S(═O)2NHR0; NH—S(═O)2N(R0)2; NR0—S(═O)2OH; NR0—S(═O)2R0; NR0—S(═O)2OR0; NR0—S(═O)2NH2; NR0—S(═O)2NHR0; NR0—S(═O)2N(R0)2; SH; SR0; S(═O)R0; S(═O)2R0; S(═O)2OH; S(═O)2OR0; S(═O)2NH2; S(═O)2NHR0; or S(═O)2N(R)2;
with the exception of the following compound:
N-benzyl-2-(3-chloro-2-hydroxypropylthio)-4-(2,4-dichlorophenyl)quinoline-3-carboxamide;
said substituted 2-mercaptoquinoline-3-carboxamide being in the form of a free compound or a salt of physiologically compatible acids or bases.

### Claim 2 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)(R0 or H); C(═O)O(R0 or H); C(═O)N(R0 or H)2; OH; OR0; O—(C1-8 alkyl)-OH; O—(C1-8 alkyl)-O—C1-8 alkyl; OCF3; O—C(═O)—R0; N(R0 or H)2; N(R0 or H)—C(═O)—R0; N(R0 or H)—C(═O)—N(R0 or H)2; SH; SCF3; SR0; S(═O)2R0; S(═O)2O(R0 or H) and S(═O)2—N(R0 or H)2;
R5 is selected from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)(R0 or H); C(═O)O(R0 or H); C(═O)N(R0 or H)2; N(R0 or H)2; N(R0 or H)—C(═O)—R0; N(R0 or H)—C(═O)—N(R0 or H)2; SH; SCF3; SR0; S(═O)2R0; S(═O)2O(R0 or H); and S(═O)2—N(R0 or H)2;
R6 stands for
C1-10 alkyl or C2-10 heteroalkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2,
C3-10 cycloalkyl or heterocyclyl or C1-8 alkyl- or C2-8 heteroalkyl-bridged C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, ═O, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2; or aryl or heteroaryl or C1-8 alkyl- or C2-8 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2; and
R7 stands for
C1-10 alkyl or C2-10 heteroalkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2;
C3-10 cycloalkyl or heterocyclyl or C1-8 alkyl- or C2-8 heteroalkyl-bridged C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, ═O, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl, and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3; S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2; or
aryl or heteroaryl or C1-8 alkyl- or C2-8 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl, and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3; and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2.

### Claim 3 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)(R0 or H); C(═O)O(R0 or H); C(═O)N(R0 or H)2; OH; OR0; O—(C1-8 alkyl)-OH; O—(C1-8 alkyl)-O—C1-8 alkyl; OCF3; O—C(═O)—R0; N(R0 or H)2; N(R0 or H)—C(═O)—R0; N(R0 or H)—C(═O)—N(R0 or H)2; SH; SCF3; SR0; S(═O)2R0; S(═O)2O(R0 or H); and S(═O)2—N(R0 or H)2;
and R5 is selected from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; R0; C(═O)(R0 or H); C(═O)O(R0 or H); C(═O)N(R0 or H)2; OR0; —O—(C1-8 alkyl)-OH; O—(C1-8 alkyl)-O—C1-8 alkyl; OCF3; O—C(═O)—R0; N(R0 or H)2; N(R0 or H)—C(═O)—R0; N(R0 or H)—C(═O)—N(R0 or H)2; SH; SCF3; SR0; S(═O)2R0; S(═O)2O(R0 or H); and S(═O)2—N(R0 or H)2.

### Claim 4 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; C(═O)H; C(═O)—OH; C(═O)—NH2; C1-8 alkyl, O—C1-8 alkyl, C(═O)C1-8 alkyl, C(═O)O—C1-8 alkyl, O—C(═O)—C1-8 alkyl, C(═O)NH—C1-8 alkyl, C(═O)N(C1-8 alkyl)2, NH—C1-8 alkyl, N(C1-8 alkyl)2, NH—C(═O)C1-8 alkyl, N(C1-8 alkyl)-C(═O)C1-8 alkyl, S—C1-8 alkyl, S(═O)2C1-8 alkyl, and S(═O)2O—C1-8 alkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, O-methyl and OH; OH; OCF3; SH; SCF3; S(═O)2OH; NH2; C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted; benzyl, phenyl, pyridyl or thienyl, each unsubstituted or mono-, di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, NH2, CN, C1-8 alkyl, O—C1-8 alkyl, CF3, OH, OCF3, C(═O)—OH, SCF3 and S(═O)2OH;
and R5 is selected from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; C(═O)H; C(═O)—OH; C(═O)—NH2; C1-8 alkyl, O—C1-8 alkyl, C(═O)C1-8 alkyl, C(═O)O—C1-8 alkyl, O—C(═O)—C1-8 alkyl, C(═O)NH—C1-8 alkyl, C(═O)N(C1-8 alkyl)2, NH—C1-8 alkyl, N(C1-8 alkyl)2, NH—C(═O)C1-8 alkyl, N(C1-8 alkyl)-C(═O)C1-8 alkyl, S—C1-8 alkyl, S(═O)2C1-8 alkyl, and S(═O)2O—C1-8 alkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O-methyl and OH; OCF3; SH; SCF3; S(═O)2OH; NH2; C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted; benzyl, phenyl, pyridyl or thienyl, each unsubstituted or mono-, di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, NH2, CN, C1-8 alkyl, O—C1-8 alkyl, CF3, OH, OCF3, C(═O)—OH, SCF3 and S(═O)2OH.

### Claim 5 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; methyl; ethyl; n-propyl; isopropyl; cyclopropyl; n-butyl; sec-butyl; tert-butyl; CH2CF3; C(═O)-methyl; C(═O)-ethyl; C(═O)—OH; C(═O)—O-methyl; C(═O)—O-ethyl; C(═O)—NH2; C(═O)—N(methyl)2; C(═O)—N(ethyl)2; C(═O)—NH-methyl; C(═O)—NH-ethyl; C(═O)—N(methyl)(ethyl)OH; O-methyl; O-ethyl; O—(CH2)2—O—CH3; O—(CH2)2—OH; OCF3; O—C(═O)-methyl; O—C(═O)-ethyl; NRaRb, wherein Ra and Rb are selected independently of each other from the group consisting of H, methyl, ethyl, (CH2)2—O—CH3 and (CH2)2—OH or Ra and Rb together with the nitrogen atom linking them form a pyrrolidinyl, piperidinyl, 4-methylpiperazinyl or morpholinyl; NHC(═O)-methyl; NHC(═O)-ethyl; SH; SCF3; S-methyl; S-ethyl; S(═O)2OH; S(═O)2O-methyl; benzyl, phenyl, pyridyl, each unsubstituted or mono-, di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, CN, methyl, ethyl, CF3, OH, O-methyl and OCF3.

### Claim 6 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R5 is selected from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; methyl; ethyl; n-propyl; isopropyl; cyclopropyl; n-butyl; sec-butyl; tert-butyl; CH2CF3; C(═O)-methyl; C(═O)-ethyl; C(═O)—OH; C(═O)—O-methyl; C(═O)—O-ethyl; C(═O)—NH2; C(═O)—N(methyl)2; C(═O)—N(ethyl)2; C(═O)—NH-methyl;
C(═O)—NH-ethyl; C(═O)—N(methyl)(ethyl)O-methyl; O-ethyl; O—(CH2)2—O—CH3; O—(CH2)2—OH; OCF3; O—C(═O)-methyl; O—C(═O)-ethyl; NRaRb, wherein Ra and Rb are selected independently of each other from the group consisting of H, methyl, ethyl, (CH2)2—O—CH3, (CH2)2—OH, C(═O)-methyl, C(═O)-ethyl or Ra and Rb together with the nitrogen atom linking them form a pyrrolidinyl, piperidinyl, 4-methylpiperazinyl or morpholinyl; SH; SCF3; S-methyl; S-ethyl; S(═O)2OH; S(═O)2O-methyl; benzyl, unsubstituted or mono-, di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, CN, methyl, ethyl, CF3, OH, O-methyl and OCF3.

### Claim 7 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R6 stands for the substructure (T1)
wherein
R8a and R86 stand independently of each other for H; F; Cl; Br; I; NO2; CF3;
CN; OH; OCF3; NH2; C1-4 alkyl, O—C1-4 alkyl, NH—C1-4 alkyl, N(C1-4 alkyl)2, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-4 alkyl, OH and OCF3; C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-4 alkyl, OH, ═O, O—C1-4 alkyl, OCF3, NH2, NH—C1-4 alkyl and N(C1-4 alkyl)2;
m stands for 0, 1, 2, 3 or 4;
Y stands for O or NR9,
wherein R9 stands for H; C1-4 alkyl, saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, C1-4 alkyl, OH, O—C1-4 alkyl, OCF3, NH2, NH—C1-4 alkyl and N(C1-4 alkyl)2; or for C3-10 cycloalkyl, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-4 alkyl, OH, O—C1-4 alkyl, OCF3, NH2, NH—C1-4 alkyl and N(C1-4 alkyl)2;
n stands for 0 or 1,
with the proviso that n does not stand for 1 if m denotes 0;
A stands for C1-8 alkyl, saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, ═O, O—C1-4 alkyl, OCF3, C(═O)—OH, CF3, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, SH, S—C1-4 alkyl, SCF3 and S(═O)2OH; C3-10 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH; aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl and thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH.

### Claim 8 (depends on 7)

Substituted carboxamide according to claim 7, wherein
R8a and R8b stand independently of each other for H; F; Cl; Br; I; NO2; CF3; CN; methyl; ethyl; n-propyl; isopropyl; cyclopropyl; n-butyl; sec-butyl; tert-butyl; CH2CF3; OH; O-methyl; O-ethyl; O—(CH2)2—O—CH3; O—(CH2)2—OH; OCF3; NH2; NH-methyl; N(methyl)2; NH-ethyl; N(ethyl)2; or N(methyl)(ethyl);
m stands for 1, 2 or 3;
n stands for 0;
A stands for C1-4 alkyl, saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, OH, O—C1-4 alkyl, OCF3 and CF3; C3-10 cycloalkyl, saturated, unsubstituted; phenyl, naphthyl, pyridyl, thienyl, each unsubstituted or mono- or di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-4 alkyl, OCF3, C1-4 alkyl, C(═O)—OH, CF3, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, SH, S—C1-4 alkyl, SCF3, and S(═O)2OH.

### Claim 9 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R7 is selected from the group consisting of methyl, ethyl, n-propyl, isopropyl, n-butyl, 2-butyl, tert-butyl, n-pentyl, isopentyl, neopentyl, n-hexyl, cyclopropyl, cyclobutyl, cyclopentyl, cyclohexyl, methyl cyclopropyl, methyl cyclobutyl, methyl cyclopentyl, methyl cyclohexyl, ethyl cyclopropyl, ethyl cyclobutyl, ethyl cyclopentyl, and ethyl cyclohexyl, each unsubstituted or mono- or polysubstituted with one or more substituents selected from the group consisting of F, Cl, Br, I, OCF3, SCF3, CF3 and OC1-8 alkyl; or phenyl, benzyl or phenethyl, each unsubstituted or mono- or polysubstituted with one or more substituents selected from the group consisting of F, Cl, Br, I, OCF3, SCF3, CF3, C1-8 alkyl, OC1-8 alkyl and CN.

### Claim 10 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; methyl; ethyl; C(═O)-methyl; OH; O-methyl; O—(CH2)2—O—CH3; OCF3; O—C(═O)-methyl; NH2; NH—C(═O)-methyl; N(methyl)2; morpholinyl; S-methyl; SCF3; benzyl and phenyl, each unsubstituted;
R5 is selected from the group consisting of H; F; Cl; Br; I; NO2; CF3; CN; methyl; ethyl; C(═O)-methyl; O-methyl; O—(CH2)2—O—CH3; OCF3; O—C(═O)-methyl; NH2; NH—C(═O)-methyl; N(methyl)2; morpholinyl; S-methyl; SCF3; benzyl, unsubstituted;
R6 stands for the substructure (T1-1)
wherein
R8a and R8b stand independently of each other for H; F; Cl; Br; I; methyl; ethyl;
n-propyl; isopropyl; n-butyl; sec-butyl; tert-butyl; OH; O-methyl; O-ethyl; O—(CH2)2—O—CH3; or O—(CH2)2—OH;
m stands for 1, 2 or 3;
A stands for methyl; ethyl; n-propyl; isopropyl; n-butyl; sec-butyl; tert-butyl; cyclopropyl; cyclobutyl; cyclopentyl; cyclohexyl; cycloheptyl; adamantyl; bicyclo[2.2.1]heptyl; bicyclo[2.2.2]octyl; phenyl, pyridyl, thienyl, each unsubstituted or mono-, di- or trisubstituted with one, two or three substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-4 alkyl, OCF3, C1-4 alkyl, C(═O)—OH, CF3, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, SH, S—C1-4 alkyl, SCF3 and S(═O)2OH;
R7 stands for
C1-8 alkyl or C2-8 heteroalkyl, each saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-8 cycloalkyl or heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3, and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2;
C3-8 cycloalkyl or heterocyclyl or C1-6 alkyl- or C2-6 heteroalkyl-bridged C3-8 cycloalkyl or heterocyclyl, each saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, ═O, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl, thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, and S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-8 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3; and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2;
aryl or heteroaryl or C1-6 alkyl- or C2-6 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3, S(═O)2OH, benzyl, phenyl, pyridyl, thienyl, wherein benzyl, phenyl, pyridyl, thienyl can each be unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, C(═O)—OH, CF3, NH2, NH(C1-8 alkyl), N(C1-8 alkyl)2, SH, S—C1-8 alkyl, SCF3 and S(═O)2OH;
and wherein optionally the alkyl chain or heteroalkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, NO2, CF3, CN, OH, ═O, C(═O)—OH, OCF3, NH2, S(═O)2OH, SH, SCF3, C1-8 alkyl, O—C1-8 alkyl, S—C1-8 alkyl, NH—C1-8 alkyl, N(C1-8 alkyl)2, C3-10 cycloalkyl and heterocyclyl, wherein the aforementioned alkyl radicals can each be saturated or unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, O—C1-8 alkyl, OH and OCF3; and wherein the aforementioned C3-10 cycloalkyl or heterocyclyl can be saturated or unsaturated, unsubstituted or mono- or polysubstituted with one or more substituents each selected independently of one another from the group consisting of F, Cl, Br, I, C1-8 alkyl, OH, ═O, O—C1-8 alkyl, OCF3, NH2, NH—C1-8 alkyl and N(C1-8 alkyl)2.

### Claim 11 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 each denote independently of one another H; F; Cl; Br; I; CF3; OH; OCF3; NH2; SH; SCF3; C1-8 alkyl, or O—C1-8 alkyl, each saturated or unsaturated, branched or unbranched, unsubstituted;
R5 stands for H; F; Cl; Br; I; CF3; OCF3; NH2; SH; SCF3; C1-8 alkyl, or O—C1-8 alkyl, each saturated or unsaturated, branched or unbranched, unsubstituted;
R6 stands for C1-8 alkyl or C2-8 heteroalkyl, each saturated, unsaturated, branched or unbranched, unsubstituted; C3-10 cycloalkyl, saturated or unsaturated, unsubstituted; aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, CF3, SH, S—C1-8 alkyl, SCF3; C1-8 alkyl- or C2-8 heteroalkyl-bridged C3-10 cycloalkyl, saturated or unsaturated, unsubstituted; or C1-8 alkyl- or C2-8 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, CF3, SH, S—C1-8 alkyl, and SCF3, wherein the alkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted;
R7 stands for C1-8 alkyl or C2-8 heteroalkyl, each saturated, unsaturated, branched or unbranched, unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, OH, ═O, O—C1-8 alkyl;
C3-10 cycloalkyl, saturated or unsaturated, unsubstituted; aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, CF3, SCF3; C1-8 alkyl- or C2-8 heteroalkyl-bridged C3-10 cycloalkyl, saturated or unsaturated, unsubstituted, wherein the alkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted; or C1-8 alkyl- or C2-8 heteroalkyl-bridged aryl or heteroaryl, each unsubstituted or mono- or polysubstituted with one or more substituents selected independently of one another from the group consisting of F, Cl, Br, I, OH, O—C1-8 alkyl, OCF3, C1-8 alkyl, CF3, and SCF3, wherein the alkyl chain can be branched or unbranched, saturated or unsaturated, unsubstituted.

### Claim 12 (depends on 1)

Substituted carboxamide according to claim 1, wherein
R1, R2, R3 and R4 are each selected independently of one another from the group consisting of H, F, Cl, CF3 and OCF3;
R5 stands for methyl, OMe or —CH2O-methyl;
R6 stands for the following substructure (T1)
wherein
R8a and R8b stand independently of each other for H,
m stands for 1,
n for 0 and
A stands for phenyl, pyridyl or thienyl, each substituted 0, 1, 2 or 3 times with a substituent selected from the group consisting of F, Cl, Br, I, NO2, CN, OH, O—C1-4 alkyl, OCF3, C1-4 alkyl, C(═O)—OH, CF3, NH2, NH(C1-4 alkyl), N(C1-4 alkyl)2, SH, S—C1-4 alkyl, SCF3 and S(═O)2OH, and
R7 stands for methyl, ethyl, isopropyl, tert-butyl or cyclopropyl.

### Claim 13 (depends on 1)

Substituted carboxamide according to claim 1, selected from the group consisting of:
1 2-(Pentylthio)-N-(2-thienylmethyl)-3-quinoline carboxamide;
2 3-[[3-[Oxo-(2-thienylmethylamino)methyl]quinolyl]thio]propanoic acid methyl ester;
3 2-(3-Cyclohexylpropylthio)-N-(2-thienylmethyl)-3-quinoline carboxamide;
4 2-(3-Phenylpropylthio)-N-(2-thienylmethyl)-3-quinoline carboxamide;
5 2-[2-(Phenylsulfonyl)ethylthio]-N-(2-thienyl-methyl)-3-quinoline carboxamide;
6 2-[3-(4-Fluorophenyl)propylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
7 2-(Ethylthio)-N-(2-thienylmethyl)-3-quinoline carboxamide;
8 2-[2-(Phenylsulfonyl)ethylthio]-N-(2-thienyl-methyl)-6-(trifluoromethyl)-3-quinoline carboxamide;
9 2-[2-(Phenylsulfonyl)ethylthio]-N-(2-thienylmethyl)-7-(trifluoromethyl)-3-quinoline carboxamide;
10 2-[2-(Phenylsulfonyl)ethylthio]-N-(2-thienylmethyl)-5-(trifluoromethyl)-3-quinoline carboxamide;
11 2-(Pentylthio)-N-(2-thienylmethyl)-6-(trifluoromethyl)-3-quinoline carboxamide;
12 2-(Ethylthio)-N-(2-thienylmethyl)-6-(trifluoromethyl)-3-quinoline carboxamide;
13 N-(2-Thienylmethyl)-2-[2-[3-(trifluoromethyl)-phenyl]sulfonylethylthio]-3-quinoline carboxamide;
14 2-(Ethylthio)-N-(2-thienylmethyl)-7-(trifluoromethyl)-3-quinoline carboxamide;
15 2-(Pentylthio)-N-(2-thienylmethyl)-7-(trifluoromethyl)-3-quinoline carboxamide;
16 2-[2-(4-Fluorophenyl)sulfonylethylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
17 2-[2-(p-Tolylsulfonyl)ethylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
18 2-[2-(p-Tolylthio)ethylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
19 2-[2-(Phenylsulfonyl)ethylthio]-N-(cyclohexylmethyl)-3-quinoline carboxamide;
20 2-[3-(p-Tolyl)propylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
21 2-[2-(Phenylthio)ethylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
22 2-[2-(Phenylsulfonyl)ethylthio]-N-(2-cyclohexylethyl)-3-quinoline carboxamide;
23 2-[2-(Phenylsulfonyl)ethylthio]-N-(3,3-dimethylbutyl)-3-quinoline carboxamide;
24 2-[2-[(4-Fluorophenyl)thio]ethylthio]-N-(2-thienylmethyl)-3-quinoline carboxamide;
N-(3,3-Dimethylbutyl)-2-(ethylthio)-4-methyl-7-(trifluoromethyl)-3-quinoline carboxamide;
26 3-(3-(Thiophen-2-ylmethylcarbamoyl)-6-(trifluoromethyl)quinolin-2-ylthio)propanoic acid methyl ester;
27 3-(3-(Thiophen-2-ylmethylcarbamoyl)-7-(trifluoromethyl)quinolin-2-ylthio)propanoic acid methyl ester;
28 N-(2,2-Dimethylpropyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
29 N-(Cycloheptylmethyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
31 N-[(3,4-Difluorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
32 N-[(2,4-Difluorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
33 2-Ethylsulfanyl-4-methyl-7-(trifluoromethyl)-N-[(3,4,5-trifluorophenyl)-methyl]-quinoline-3-carboxamide;
34 2-Ethylsulfanyl-4-methyl-7-(trifluoromethyl)-N-[(2,4,5-trifluorophenyl)-methyl]-quinoline-3-carboxamide;
35 2-Ethylsulfanyl-4-methyl-N-(pyridin-4-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
36 N-[(4-tert-Butylphenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
37 2-Ethylsulfanyl-4-methyl-N-(3-methylbutyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
38 2-Ethylsulfanyl-4-methyl-7-(trifluoromethyl)-N-[[3-(trifluoromethyl)phenyl]-methyl]-quinoline-3-carboxamide;
39 2-Ethylsulfanyl-4-methyl-N-phenethyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
40 2-Ethylsulfanyl-4-methyl-N-(3-phenylpropyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
41 2-Ethylsulfanyl-4-methyl-N-(pyridin-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
42 2-Ethylsulfanyl-4-methyl-N-(pyridin-3-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
43 2-Ethylsulfanyl-4-methyl-N-(naphthalen-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
44 2-Ethylsulfanyl-4-methyl-N-(thiazol-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
45 2-Ethylsulfanyl-4-methyl-N-([1,3,4]oxadiazol-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
47 N-[(3-Fluorophenyl)-methyl]-2-(isopropylsulfanyl)-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
48 2-(Cyclopentylsulfanyl)-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
49 2-(Butylsulfanyl)-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
50 N-[(3-Fluorophenyl)-methyl]-4-methyl-2-(pentylsulfanyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
51 N-[(3-Fluorophenyl)-methyl]-4-methyl-2-(1-methyl-propylsulfanyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
52 2-(Cyclohexylsulfanyl)-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
53 N-(2-Cyclopentylethyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
54 N-(3-Cyclopentylpropyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
55 2-Ethylsulfanyl-4-methyl-7-(trifluoromethyl)-N-[[4-(trifluoromethyl)phenyl]-methyl]-quinoline-3-carboxamide;
56 N-[(3-tert-Butylphenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
57 2-Ethylsulfanyl-4-methyl-N-(4-methylpentyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
58 2-Benzylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
59 2-Ethylsulfanyl-N-[(3-fluoro-2-methoxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
60 2-Ethylsulfanyl-N-[(5-fluoro-2-methoxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
61 N-[(3,4-Dimethyl phenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
62 2-Ethylsulfanyl-4-methyl-7-(trifluoromethyl)-N-[[4-(trifluoromethylsulfanyl)-phenyl]-methyl]-quinoline-3-carboxamide;
63 N-(Cyclohexylmethyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
64 2-Ethylsulfanyl-4-methyl-N-(tetrahydropyran-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
65 2-Ethylsulfanyl-4-methyl-N-propyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
66 N-Butyl-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
67 2-Ethylsulfanyl-N-(2-methoxyethyl)-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
68 2-Ethylsulfanyl-4-methyl-N-pentyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
69 2-Ethylsulfanyl-4-methyl-N-[(5-methylthiophen-2-yl)-methyl]-7-(trifluoromethyl)-quinoline-3-carboxamide;
70 2-Ethylsulfanyl-4-methyl-N-[(4-methylthiophen-2-yl)-methyl]-7-(trifluoromethyl)-quinoline-3-carboxamide;
71 N-[(5-Chlorothiophen-2-yl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
72 2-Ethylsulfanyl-4-methyl-N-(2-thiophen-2-yl-ethyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
73 N-(5-Bicyclo[2.2.1]heptanylmethyl)-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
74 N-Benzyl-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
75 2-Ethylsulfanyl-N-[(2-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
76 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
77 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
78 N-[(2-Chlorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
79 N-[(3-Chlorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
80 N-[(4-Chlorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
81 2-Ethylsulfanyl-4-methyl-N-(o-tolylmethyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
82 2-Ethylsulfanyl-4-methyl-N-(m-tolylmethyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
83 2-Ethylsulfanyl-4-methyl-N-(p-tolylmethyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
84 2-Ethylsulfanyl-N-[(2-methoxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
85 2-Ethylsulfanyl-N-[(3-methoxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
86 2-Ethylsulfanyl-N-[(4-methoxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
87 N-[(3,5-Difluorophenyl)-methyl]-2-ethylsulfanyl-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
88 4-Methyl-2-methylsulfanyl-N-(thiophen-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
89 2-(tert-Butylsulfanyl)-4-methyl-N-(thiophen-2-yl-methyl)-7-(trifluoromethyl)-quinoline-3-carboxamide;
90 N-(2,2-Dimethylpropyl)-2-ethylsulfanyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
91 2-Ethylsulfanyl-4-methyl-N-(thiophen-2-yl-methyl)-quinoline-3-carboxamide;
92 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
93 2-(tert-Butylsulfanyl)-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
94 2-(tert-Butylsulfanyl)-N-[(4-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
95 7-tert-Butyl-2-ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
96 7-tert-Butyl-2-ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
97 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-7-methoxy-4-methyl-quinoline-3-carboxamide;
98 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-7-methoxy-4-methyl-quinoline-3-carboxamide;
99 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4,6-dimethyl-quinoline-3-carboxamide;
100 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4,6-dimethyl-quinoline-3-carboxamide;
101 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-6-methoxy-4-methyl-quinoline-3-carboxamide;
102 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-6-methoxy-4-methyl-quinoline-3-carboxamide;
103 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-6-(trifluoromethyl)-quinoline-3-carboxamide;
104 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-6-(trifluoromethyl)-quinoline-3-carboxamide;
105 2-Ethylsulfanyl-7-fluoro-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
106 2-Ethylsulfanyl-7-fluoro-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
107 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4,7-dimethyl-quinoline-3-carboxamide;
108 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4,7-dimethyl-quinoline-3-carboxamide;
109 2-Ethylsulfanyl-6,7-difluoro-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
110 2-Ethylsulfanyl-N-(furan-2-yl-methyl)-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
111 2-Ethylsulfanyl-4-methyl-N-[(5-methyl-furan-2-yl)-methyl]-7-(trifluoromethyl)-quinoline-3-carboxamide;
113 2-Ethylsulfanyl-N-[(3-hydroxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
114 N-[(3-Fluorophenyl)-methyl]-4-methyl-2-methylsulfanyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
115 N-[(4-Fluorophenyl)-methyl]-4-methyl-2-methylsulfanyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
116 2-Ethylsulfanyl-6-fluoro-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
117 2-Ethylsulfanyl-6-fluoro-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
118 2-Ethylsulfanyl-6,7-difluoro-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
119 2-Ethylsulfanyl-N-[(4-hydroxyphenyl)-methyl]-4-methyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
120 2-Ethylsulfanyl-8-fluoro-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
121 2-Ethylsulfanyl-8-fluoro-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
123 2-Ethylsulfanyl-5-fluoro-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
124 2-Ethylsulfanyl-5-fluoro-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
125 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-5-methoxy-4-methyl-quinoline-3-carboxamide;
126 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-5-methoxy-4-methyl-quinoline-3-carboxamide;
127 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-5-hydroxy-4-methyl-quinoline-3-carboxamide;
128 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-6-hydroxy-4-methyl-quinoline-3-carboxamide;
129 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-7-hydroxy-4-methyl-quinoline-3-carboxamide;
133 7-Dimethylamino-2-ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
134 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-7-morpholin-4-yl-quinoline-3-carboxamide;
135 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-7-morpholin-4-yl-quinoline-3-carboxamide;
136 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-8-(trifluoromethyl)-quinoline-3-carboxamide;
137 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-4-methyl-8-(trifluoromethyl)-quinoline-3-carboxamide;
138 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-8-methoxy-4-methyl-quinoline-3-carboxamide;
139 2-Ethylsulfanyl-N-[(4-fluorophenyl)-methyl]-8-methoxy-4-methyl-quinoline-3-carboxamide;
140 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-8-hydroxy-4-methyl-quinoline-3-carboxamide;
141 7-Dimethylamino-2-ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-quinoline-3-carboxamide;
142 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-methyl-7-(trifluoromethyloxy)-quinoline-3-carboxamide;
143 4-Ethyl-2-ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-7-(trifluoromethyl)-quinoline-3-carboxamide;
144 2-Ethylsulfanyl-N-[(3-fluorophenyl)-methyl]-4-isopropyl-7-(trifluoromethyl)-quinoline-3-carboxamide;
and the physiologically compatible salts thereof.

### Claim 14 (depends on 1)

A pharmaceutical composition comprising at least one substituted carboxamide according to claim 1 or the compound N-benzyl-2-(3-chloro-2-hydroxypropylthio)-4-(2,4-dichlorophenyl)quinoline-3-carboxamide,
in the form of an individual stereoisomer or a mixture thereof, in the form of a free compound and/or a physiologically compatible salt thereof, and optionally one or more suitable additives and/or auxiliary substances and/or optionally further active ingredients.

### Claim 15 (depends on 1)

A method of treating a disorder in a patient in need of such treatment, said disorder being at least one disorder selected from the group consisting of pain, epilepsy, urinary incontinence, anxiety states, dependency, mania, bipolar disorders, migraine, cognitive diseases, and dystonia-associated dyskinesias, said method comprising administering to said patient an amount effective to treat said disorder of at least one substituted carboxamide according claim 1 or the compound N-benzyl-2-(3-chloro-2-hydroxypropylthio)-4-(2,4-dichlorophenyl)quinoline-3-carboxamide,
each in the form of an individual stereoisomer or a mixture thereof, in the form of a free compound and/or a physiologically compatible salt thereof.
